Page results
-
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.
-
The National Hospital for Neurology and Neurosurgery (NHNN), part of UCLH NHS Foundation Trust, has been reaccredited under the prestigious Royal College of Anaesthetists (RCoA) Anaesthesia Clinical Services Accreditation (ACSA) demonstrating the hospital anaesthetists’ commitment to patient safety and excellence of care.
-
Neurological complications of COVID-19 can include delirium, brain inflammation, stroke and nerve damage, finds a new UCL and UCLH-led study.
-
UCLH will be part of a major UK research study looking at the long-term health impacts of COVID-19.
-
Mr Attilakos is a consultant in fetal medicine and obstetrics who specialises in looking after complicated and uncomplicated multiple pregnancies.
-
Dr Alegre Abarrategui is a consultant in diagnostic neuropathology offering diagnostic services across neuropathology subspecialties, especially surgical neuropathology, neuromuscular neuropathology, and neurodegeneration.
-
Testing for NHS staff, provided by the Francis Crick Institute and UCLH NHS Foundation Trust, detected COVID-19 infections that would have otherwise been missed.
-
A breathing pattern disorder is an alteration/abnormal pattern of breathing.
-
This page is for patients who have been referred on a suspected cancer pathway.
-
Outcome of National Institute for Health and Care Excellence (NICE) Technology Appraisal for Exagamglogene autotemcel (Exa-cel) for treating transfusion- dependent beta thalassaemia [ID4015] in individuals 12 years and over.
File results
-
FOI/2024/0259 - Clinical attachments for international medical graduates
-
FOI/2024/0263 - Longest wait for ophthalmology pathway treatment
-
FOI/2024/0268 - Module on imaging offered to PAs as training in requesting ionising radiation
-
FOI/2024/0269 - Paediatric audiology services
-
FOI/2024/0273 - Covid restrictions for visitors at Elizabeth Garret Anderson (EGA) from December 2021-June 2022
-
FOI/2024/0274 - Number of endoscopes at Trust
-
FOI/2024/0277 - Paediatric respiratory admission rates 2018-2023
-
FOI/2024/0467 - Drug Patient Level Contract Monitoring (DrPLCM) and SACT Cancer reports
-
FOI/2024/0464 - Theatre sessions/ productivity
-
FOI/2024/0329 - Metastatic renal cell carcinoma patients/ classification